Search - tctmd.com

Displaying 101 - 120 of 122

Sort: Relevancy | Date

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Presenter: Somjot S. Brar, Richard Solomon, Philippe Généreux

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

Presentation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Presenter: Nissen Bonde

December 08, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

Presentation TCT 2014

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Felix Mahfoud

September 14, 2014

Presentation Cell Therapy 2014

Effective treatment of rats with Acute Kidney Injury (AKI) and Acute on Chronic Kidney Disease with syngeneic or human Adipose-Derived Stem Cells and comparison with MSCs

Presenter: Christof Westenfelder

January 23, 2014

Presentation TCT 2013

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

Presenter: Usman Baber

October 29, 2013

Presentation

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Presenter: Yaling Han

October 09, 2013

Presentation TCT 2013

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho

January 31, 2013

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

Presentation TCT 2012

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Presenter: Roxana Mehran

October 23, 2012

Advertisement

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Effective treatment of rats with Acute Kidney Injury (AKI) and Acute on Chronic Kidney Disease with syngeneic or human Adipose-Derived Stem Cells and comparison with MSCs

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content